Cliniko
👤 Joel Friedlaender (Joel's a dev; wife Liora is a practising osteopath. He built for her exact clinic workflow — access no generalist rival had.)🌐 site𝕏
Cliniko runs booking, records and billing for 65,000+ physios, chiros and osteopaths in 95 countries — with zero VC.
Will it work? · our read
Trust compounds. The moat is 14 years of profession-insider trust you can't clone. In a crowded, funded category, Cliniko wins by staying patient and deep inside allied health.
01How the money moves
Allied-health clinic imports its patient records and bookings
→
Runs scheduling, notes, invoicing and online payments daily
→
Pays one flat monthly band fee — sticky, low-churn MRR
02The numbers
65,000+
practitioners
cliniko.com
95
countries
cliniko.com
AU$3M+
given to charity
cliniko.com
No outside investment — 100% founder-owned since 2011. cliniko.com/charity
No public ARR; about AU$22M/yr implied by the 2%+ charity pledge (Latka's $1.5M is not credible).
03Weight class — CENTStap an axis
Control High
Owns the product and direct billing; sticky clinical data, no platform or ad-channel dependency.
04The key move
One price per clinic
Cliniko bills per clinic band, not per seat: a 5-practitioner clinic pays AU$95 total, not 5 seats, leaving real ARPU on the table versus per-seat rivals.
fact
The counter-intuitive move
Forgoing that ARPU is the bet: it fuels the word-of-mouth that sells Cliniko in a tight-knit profession, beating the ARR a funded per-seat rival would extract.
our read
05Where the moat is
Why rivals with more money still can't buy the category:
Patient records lock-in — clinics rarely switch14 years of trust in a referral-dense nicheInsider co-founder: a practising osteopath65K+ practitioners across 95 countries
06How it diesmedium confidence
The losing twin: a generalist ships another booking app with no clinical depth and gets out-spent by funded rivals. Without insider trust and years of patience, this crowded niche eats bootstrappers alive. our read
Show evidence · counter
Evidence: Cliniko has already outlasted better-funded entrants; insider trust in allied health has proven durable, not a one-off.
Counter: Cliniko has already outlasted better-funded entrants; insider trust in allied health has proven durable, not a one-off.
07Against rivals
SimplePractice's parent EngageSmart took growth capital, IPO'd, then went private under Vista Equity (PE) in 2024 — outside capital Cliniko never took. our read
08Who uses it
PhysiotherapistsChiropractorsOsteopathsMassage therapistsPodiatrists
★Would it work for you?
Is there a boring profession whose exact workflow and trust you can get from the inside — a spouse, a friend, a past job?
Cliniko's edge was Liora, a real osteopath in the room. What door opens for you? We don't score you — you answer.
🚀Use it as a launchpada prompt for your own AI
Copy → paste into your AI → then develop it freely in the conversation.
You are a sharp, honest startup strategist. Use the proven case below as a launchpad for MY idea — help me find my own angle, not copy it.
<my_profile>
Domain I know: [your domain]
My unfair advantage (access/audience): [your edge]
Interests: [your interests]
Resources & goal: [your resources] · [your goal]
</my_profile>
<case name="Cliniko" model="saas">
What it does: A cloud practice-management app for allied-health clinics: booking, patient records, notes, invoicing and online payments.
Why it won (moat): Insider trust: co-built by a practising osteopath, compounded over 14 bootstrapped years in a referral-dense niche.
Weakest axis (CENTS): Crowded category — funded rivals like SimplePractice, Jane and Halaxy chase the same clinics.
How it could die: Cliniko dies if it out-prices its goodwill, or a funded rival buys the category with ads before word-of-mouth compounds.
</case>
<task>
Be a skeptical operator, not a cheerleader. No generic startup platitudes. If my angle is weak, say so plainly.
First, a reality check: markets like this mostly fail. State the honest base rate (how crowded/hard is this?) and the ONE specific thing that would have to be true for ME to be the exception — grounded in my profile above.
Then a compact table:
- Fit — does this pattern suit my edge, or fight my gap?
- Angle — my sharpest differentiation vs Cliniko (concrete, not "better UX")
- Distribution — exactly where my first 100 users come from (this is the hardest part — be specific, not "content marketing")
- Risk — its "how it dies" (above) in MY situation
Finish with one line: "The single thing to do next."
Use only the facts above; if data is thin, say so — never invent numbers.
Then stay with me and go deeper on whatever I ask — tech stack, rough cost & time, the smallest MVP to test, pricing, or timing.
</task>
✓ Copied — paste into your AI
👤Placeholders like [your domain] auto-fill from your profile — example values for now.Set up profile →
Sourcesupdated · daily
Cliniko — The Cliniko story (Joel + Liora, 2011 launch, home-loan start)Cliniko — Charity (min 2% of revenue; AU$3M+ given)Cliniko — Pricing (flat per-clinic bands, AU$45-395/mo)Cliniko blog — 'Investment? No thanks' (no VC)Joel Friedlaender on X (@jfriedlaender)
Revenue is estimated, not disclosed — Cliniko publishes no ARR. Derived from its first-party giving pledge: recent charity donations run about AU$500K/yr (AU$1.8M by Jul 2023 to AU$3M+ by Oct 2025) at the pledged 2%+ of revenue, implying roughly AU$17-27M/yr (about US$11-17M); I use AU$22M as the midpoint. Latka's '$1.5M ARR' is not credible — 2% of that is $30K, versus the about $500K actually given. Firm first-party facts: 65,000+ practitioners, 95 countries, no VC, a home-renovation-loan start, a 30-hour week, AU$3M+ to charity, and co-founder Liora being a practising osteopath (the insider edge). The pricing bands and the per-clinic-not-per-seat billing are fact; the claim that leaving that ARPU on the table drives referrals is [our read], now split into keyMove.counter rather than folded into the fact badge. We never score you.